Home › Pagkabigo ng Puso › South Carolina
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa South Carolina
30 pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa mga site sa South Carolina.
Mga Lungsod sa South Carolina
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Spartanburg
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Medical University of South Carolina - Gazes Research Institute, Charleston
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06736574Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
- Medical University of South Carolina, Charleston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07222813A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Bon Secours Medical Group Greenville Specialty Care, LLC, Greenville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06424288Alleviant ALLAY-HFrEF Study
- Roper St. Francis Healthcare, Charleston
- Medical University of South Carolina, Charleston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06812533Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Columbia
- Research Site, Fort Mill
- Research Site, Mt. Pleasant
- at 2 pa
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06677060Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Charleston
- Research Site, Charleston
- Research Site, Lancaster
Nagre-recruitPhase 3
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06307652A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Charleston, SC Investigative Site 10056, Charleston
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06008197The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
- MUSC, Charleston
Nagre-recruitObservasyonal na pag-aaral
Edad 22 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07098858Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Medical University of South Carolina, Charleston
Nagre-recruit
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06310031A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 142, Charleston
Nagre-recruitPhase 2
Edad 30 hanggang 84 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07795814Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- AnMed Health, Anderson
Nagre-recruit
Edad 21 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05677100Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Columbia
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Prisma Health - Upstate, Greenville
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Charleston
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Med. Uni. of SC Ashley River T, Charleston
- Piedmont Research Partners, LLC, Fort Mill
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07567001Alleviant ALLAY-HF Study
- Medical University of South Carolina, Charleston
- Prisma Health - Midlands, Colombia
Nagre-recruit
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT05685303OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
- Medical University of South Carolina, Charleston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06939751Assessment of CCM in HF With Higher Ejection Fraction
- Prisma Health Upstate, Greenville
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05064709ELEVATE-HFpEF Clinical Study
- Medical University of South Carolina (MUSC), Charleston
Nagre-recruit
Edad 40 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06678841A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- Orangeburg, SC Investigative Site FIN-10433, Orangeburg
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06033950A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
- Medical University of South Carolina, Charleston
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT07137338PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Medical University of South Carolina (MUSC), Charleston
- PRISMA Health- Upstate, Greenville
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT05934487A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- MUSC Shawn Jenkins Children's Hospital - Cardiology, North Charleston
Nagre-recruitPhase 3
Hanggang edad 18 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- MUSC Shawn Jenkins Children's Hospital - Cardiology, North Charleston
Nagre-recruitPhase 3
6 Months – 17 Years · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT07188805Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Medical University of South Carolina, Charleston
- Prisma Health Midlands, Columbia
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06526195Precision Rehabilitation for Veterans With (HFpEF)
- Columbia VA Health Care System, Columbia
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 25, 2026 · NCT07493915Left vs Left Randomized Clinical Trial
- Medical University of South Carolina (MUSC), Charleston
- Prisma Health-Upstate, Greenville
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05650658Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Medical University of South Carolina, Charleston
Nagre-recruitObservasyonal na pag-aaral
Edad 14 hanggang 65 · Lahat ng kasarian · Na-update Nob 1, 2024 · NCT06311708HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
- Prisma Health, Columbia
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update May 22, 2024 · NCT06425848Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.